BioMark Diagnostics Inc.
BUX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.18M | -1.24M | -1.39M | -1.39M | -1.45M |
| Total Depreciation and Amortization | 335.30K | 315.10K | 284.70K | 201.40K | 232.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.00K | 155.30K | 311.10K | 288.80K | 290.90K |
| Change in Net Operating Assets | -234.80K | 11.90K | 13.40K | 271.00K | 61.10K |
| Cash from Operations | -1.01M | -752.80K | -780.70K | -624.90K | -861.50K |
| Capital Expenditure | -8.40K | -2.10K | -2.50K | -2.70K | -4.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -592.20K | -1.36M | -- | -- | -- |
| Cash from Investing | -600.60K | -1.36M | -2.50K | -2.70K | -4.30K |
| Total Debt Issued | 378.20K | 378.20K | 378.20K | 378.20K | 357.20K |
| Total Debt Repaid | -632.50K | -601.40K | -567.80K | -773.70K | -1.07M |
| Issuance of Common Stock | 3.19M | 3.24M | 3.61M | 1.03M | 1.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.04M | 2.10M | 2.40M | 460.70K | 766.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 435.40K | -12.80K | 1.62M | -166.80K | -99.00K |